LINC01287: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC01287

NCBI ID: G103724390

LINC01287

Other Name(s): long intergenic non-protein coding RNA 1287 | TCONS_l2_00027522 | Long intergenic non-protein coding RNA 1287

LINC01287: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC01287 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified using RNA-seq technology. This RNA is different from traditional proteins in that it is not made by translation of mRNA, but rather by the process of RNA synthesis from DNA. LINC01287 has been shown to play a role in various cellular processes, including cell growth, differentiation, and metabolism.

Drug Targeting

One of the potential applications of LINC01287 as a drug target is its ability to modulate cellular processes that are associated with various diseases, such as cancer, neurodegenerative diseases, and metabolic disorders. LINC01287 has been shown to be involved in several cellular processes that are associated with disease development, including cell proliferation, angiogenesis, and autophagy.

For example, LINC01287 has been shown to be involved in the regulation of cell proliferation in various tissues, including the brain, and has been linked to the development of neurodegenerative diseases. Additionally, LINC01287 has been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels are formed, and has been linked to the development of cardiovascular diseases.

Biomarker

Another potential application of LINC01287 as a biomarker is its ability to serve as a gene expression marker for diseases. LINC01287 has been shown to be highly expressed in a variety of tissues and has been used as a gene expression marker for diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

For example, LINC01287 has been shown to be highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer, and has been used as a potential biomarker for these diseases. Additionally, LINC01287 has been shown to be involved in the regulation of metabolism and has been linked to the development of diseases such as obesity and type 2 diabetes.

Conclusion

In conclusion, LINC01287 is a long intergenic non-protein-coding RNA that has been shown to play a role in various cellular processes and has the potential to be a drug target or biomarker. Further research is needed to fully understand the role of LINC01287 in disease development and to determine its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1287

The "LINC01287 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01287 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets